Tags:BioTechDevelopmentDrugFinTechFutureScienceTechnologyWebsite
We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
Location: Denmark, Capital Region of Denmark, Copenhagen
Total raised: $50M

Investors 3

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
11.03.2019Series A$50M-fiercebiot...

Mentions in press and media 20

DateTitleDescriptionCategoryAuthorSource
31.05.2023SNIPR Biom...SNIPR001 demonstrates proof of...--en.prnasia...
31.05.2023SNIPR Biom...SNIPR Biome reports positive c...--news.cisio...
05.05.2023SNIPR Biom...SNIPR001 is a novel CRISPR-Cas...--en.prnasia...
04.05.2023SNIPR Biom...SNIPR Biome's data on first cl...--news.cisio...
22.12.2022SNIPR Biom...SNIPR Biome further strengthen...--news.cisio...
20.04.2022SNIPR BIOM...COPENHAGEN, Denmark, April 20,...--en.prnasia...
20.04.2022SNIPR BIOM...SNIPR BIOME Initiates First-in...--news.cisio...
16.03.2022SNIPR BIOM...SNIPR BIOME expands its Execut...--news.cisio...
16.03.2022SNIPR BIOM...COPENHAGEN, Denmark, March 16,...--en.prnasia...
08.03.2022SNIPR BIOM...SNIPR BIOME announces opening ...--news.cisio...
Show more